BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1107261 HOUSTON, TX

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$332,500

-$133,000 QoQ

Shares Held

25,000

-50.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#85

of 158 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,496,321 across 108 Biotechnology names. FDMT ranks #57 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$332,500	25,000	-50.0%	Shares	Sole	2026-08-14
2026-03-31	$465,500	50,000	0.0%	Shares	Sole	2026-05-15
2025-12-31	$375,000	50,000	0.0%	Shares	Sole	2026-02-17
2025-09-30	$434,500	50,000	+100.0%	Shares	Sole	2025-11-14
2025-06-30	$92,750	25,000	+100.3%	Shares	Sole	2025-08-14
2025-03-31	$40,323	12,484	-28.3%	Shares	Sole	2025-05-15
2023-12-31	$352,524	17,400	-36.5%	Shares	Sole	2024-02-14
2023-09-30	$348,802	27,400	0.0%	Shares	Sole	2023-11-14
2023-06-30	$495,118	27,400	0.0%	Shares	Sole	2023-08-14
2023-03-31	$471,006	27,400	-35.4%	Shares	Sole	2023-05-15
2022-12-31	$941,704	42,400	-26.1%	Shares	Sole	2023-02-14
2022-09-30	$461,496	57,400	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.